Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side

Last updated: September 4, 2025
Sponsor: Orbis
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes And Hypertension

Diabetes Prevention

Diabetic Retinopathy

Treatment

care recommendations

Clinical Study ID

NCT06968637
PIS-DR-SUPPLY-2025
  • Ages > 30
  • All Genders

Study Summary

The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of diabetes alongside feedback on positive eye exams for DR can improve diabetes care outcomes.

The main questions it aims to answer are:

  1. Does delivery of specific diabetes management recommendations to diabetes doctors for patients of theirs found to have DR lead to significantly improved blood glucose control as indicated by % reaching WHO targets of HbA1c (or targets for blood sugar if HbA1c data are unavailable)?

  2. What is the cost-effectiveness of the intervention, measured as total intervention cost per additional participant reaching the WHO target?

Researchers will compare participant adherence with international guidelines when DR results are provided by a PIS without specific care recommendations to when the PIS provides DR results with specific care recommendations for DM management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with DM

  • Diagnosed with DR in at least one eye

  • Over 30 years of age

  • Currently treated at the Dinajpur Diabetes Hospital and Gausul Azam BNSB EyeHospital in Bangladesh

  • willingness to participate in the study

Exclusion

Exclusion Criteria:

  • Any ocular condition impairing the view of the fundus sufficiently to precludegrading of the image for DR.

  • Inability to comply with retinal photography to the extent that a gradable imagecannot be captured, or any other factor leading to absence of sufficient images tograde at least one eye of a participant.

  • Medical conditions that could impair compliance with follow-up (such as stroke,dementia, etc.)

  • Unwilling to participate in the study, or incapable of giving informed consent.

Study Design

Total Participants: 336
Treatment Group(s): 1
Primary Treatment: care recommendations
Phase:
Study Start date:
August 25, 2025
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • Dinajpur Diabetes & Swasthoseba Hospital

    Dinajpur Sadar, Dinajpur 5200
    Bangladesh

    Active - Recruiting

  • Gausul Azam BNSB Eye Hospital

    Dinajpur District,
    Bangladesh

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.